Zymeworks Inc.
ZYME- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001937653
No open-market purchases or sales by Zymeworks Inc. insiders were filed in the last 90 days; 202 institutions reported holding it in 13F filings for Q2 2026, worth $1.79B in total; no superinvestor holds it.
13F holders, Q3 2022
Institutional positions in Zymeworks Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 91
- −23 vs. Q2 2022
- Shares held
- 47.8M
- +73.5K (+0.2%) vs. Q2 2022
- Total value
- $293.7M
- +$40.5M (+16.0%) vs. Q2 2022
- New holders
- 11
- 27 more added
- Sold out
- 34
- 27 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ZYME on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 202 | $1.79B |
| Q1 2026 | 212 | $1.76B |
| Q4 2025 | 210 | $1.88B |
| Q3 2025 | 184 | $1.26B |
| Q2 2025 | 182 | $949.0M |
| Q1 2025 | 186 | $840.9M |
| Q4 2024 | 174 | $973.2M |
| Q3 2024 | 163 | $834.7M |
| Q2 2024 | 164 | $580.6M |
| Q1 2024 | 171 | $713.0M |
| Q4 2023 | 157 | $674.0M |
| Q3 2023 | 140 | $395.5M |
| Q2 2023 | 137 | $547.9M |
| Q1 2023 | 116 | $512.6M |
| Q4 2022 | 96 | $449.9M |
| Q3 2022 | 91 | $293.7M |
| Q2 2022 | 114 | $253.3M |
| Q1 2022 | 120 | $327.3M |
| Q4 2021 | 114 | $693.9M |
| Q3 2021 | 123 | $1.07B |
| Q2 2021 | 109 | $1.20B |
| Q1 2021 | 125 | $1.12B |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Zymeworks Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| HRT Financial LP | 0 | $0 | 0.00% | −133,794−100.0% | Sold out |
| Parkman Healthcare Partners LLC | 0 | $0 | 0.00% | −125,806−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −71,600−100.0% | Sold out |
| Dynamic Technology Lab Private Ltd | 0 | $0 | 0.00% | −61,351−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −55,646−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −55,500−100.0% | Sold out |
| Pura Vida Investments, LLC | 0 | $0 | 0.00% | −44,696−100.0% | Sold out |
| Diametric Capital, LP | 0 | $0 | 0.00% | −30,002−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −25,049−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −21,943−100.0% | Sold out |
| Prelude Capital Management, LLC | 0 | $0 | 0.00% | −18,570−100.0% | Sold out |
| Blueshift Asset Management, LLC | 0 | $0 | 0.00% | −18,215−100.0% | Sold out |
| Fox Run Management, L.L.C. | 0 | $0 | 0.00% | −16,871−100.0% | Sold out |
| Ensign Peak Advisors, Inc | 0 | $0 | 0.00% | −15,620−100.0% | Sold out |
| First Republic Investment Management, Inc. | 0 | $0 | 0.00% | −15,000−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −13,269−100.0% | Sold out |
| Envestnet Asset Management Inc | 0 | $0 | 0.00% | −11,614−100.0% | Sold out |
| Quantbot Technologies LP | 0 | $0 | 0.00% | −10,300−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −5,184−100.0% | Sold out |
| Skandinaviska Enskilda Banken AB (publ) | 0 | $0 | 0.00% | −4,725−100.0% | Sold out |
| US Bancorp | 0 | $0 | 0.00% | −46−100.0% | Sold out |
| Toronto Dominion Bank | 0 | $0 | 0.00% | −16−100.0% | Sold out |
| Asset Dedication, LLC | 0 | $0 | 0.00% | −47−100.0% | Sold out |
| Allworth Financial LP | 0 | $0 | 0.00% | −92−100.0% | Sold out |
| CoreCap Advisors, LLC | 0 | $0 | 0.00% | −18−100.0% | Sold out |